Health care workers answer questions about the COVID-19 vaccines.
Orlando Harris, PhD, FNP, MPH explains how the U.S. government was involved in COVID vaccine research.
So under operation warp speed, because of the need to develop a vaccine candidate quickly, you had partnership between the U.S. government and these drug companies.
With the timeline or the timetable for drug companies to put up all of that money to develop the candidate, it’s just not feasible.
And at the same time, to move the vaccine process quickly, we already paid for the manufacturing and distribution of up to 300 million doses of vaccines as part of our partnership with these different pharmaceutical companies.
